2,561
Views
33
CrossRef citations to date
0
Altmetric
Review Article

Salt intake, plasma sodium, and worldwide salt reduction

&
Pages S127-S137 | Received 26 Sep 2010, Accepted 27 Dec 2010, Published online: 19 Jun 2012

References

  • MacGregor GA, de Wardener HE. Salt, diet and health. Cambridge: Cambridge University Press; 1998.
  • Brown IJ, Tzoulaki I, Candeias V, Elliott P. Salt intakes around the world: implications for public health. Int J Epidemiol. 2009;38:791–813.
  • He FJ, MacGregor GA. Reducing population salt intake worldwide: from evidence to implementation. Prog Cardiovasc Dis. 2010;52:363–82.
  • Intersalt: an international study of electrolyte excretion and blood pressure. Results for 24 hour urinary sodium and potassium excretion. Intersalt Cooperative Research Group. BMJ. 1988;297:319–28.
  • Tobian L, Hanlon S. High sodium chloride diets injure arteries and raise mortality without changing blood pressure. Hypertension. 1990;15:900–3.
  • Perry IJ, Beevers DG. Salt intake and stroke: a possible direct effect. J Hum Hypertens. 1992;6:23–5.
  • Messerli FH, Schmieder RE, Weir MR. Salt. A perpetrator of hypertensive target organ disease? Arch Intern Med. 1997;157:2449–52.
  • Cianciaruso B, Bellizzi V, Minutolo R, Tavera A, Capuano A, Conte G, . Salt intake and renal outcome in patients with progressive renal disease. Miner Electrolyte Metab. 1998;24:296–301.
  • He FJ, Markandu ND, Sagnella GA, MacGregor GA. Effect of salt intake on renal excretion of water in humans. Hypertension. 2001;38:317–20.
  • He FJ, Marrero NM, MacGregor GA. Salt intake is related to soft drink consumption in children and adolescents: a link to obesity? Hypertension. 2008;51:629–34.
  • Cappuccio FP, Kalaitzidis R, Duneclift S, Eastwood JB. Unravelling the links between calcium excretion, salt intake, hypertension, kidney stones and bone metabolism. J Nephrol. 2000;13:169–77.
  • Joossens JV, Hill MJ, Elliott P, Stamler R, Lesaffre E, Dyer A, . Dietary salt, nitrate and stomach cancer mortality in 24 countries. European Cancer Prevention (ECP) and the INTERSALT Cooperative Research Group. Int J Epidemiol. 1996;25:494–504.
  • Tsugane S, Sasazuki S, Kobayashi M, Sasaki S. Salt and salted food intake and subsequent risk of gastric cancer among middle-aged Japanese men and women. Br J Cancer. 2004;90:128–34.
  • Mohan S, Campbell NR. Salt and high blood pressure. Clin Sci (Lond). 2009;117:1–11.
  • Denton D, Weisinger R, Mundy NI, Wickings EJ, Dixson A, Moisson P, . The effect of increased salt intake on blood pressure of chimpanzees. Nat Med. 1995;1:1009–16.
  • Elliott P, Walker LL, Little MP, Blair-West JR, Shade RE, Lee DR, . Change in salt intake affects blood pressure of chimpanzees: implications for human populations. Circulation. 2007;116:1563–8.
  • Zhou BF, Stamler J, Dennis B, Moag-Stahlberg A, Okuda N, Robertson C, . Nutrient intakes of middle-aged men and women in China, Japan, United Kingdom, and United States in the late 1990s: the INTERMAP study. J Hum Hypertens. 2003;17:623–30.
  • Khaw KT, Bingham S, Welch A, Luben R, O'Brien E, Wareham N, . Blood pressure and urinary sodium in men and women: the Norfolk Cohort of the European Prospective Investigation into Cancer (EPIC-Norfolk). Am J Clin Nutr. 2004;80:1397–403.
  • Elliott P, Stamler J. Evidence on salt and blood pressure is consistent and persuasive. Int J Epidemiol. 2002;31: 316–9.
  • Elliott P, Stamler J, Nichols R, Dyer AR, Stamler R, Kesteloot H, . Intersalt revisited: further analyses of 24 hour sodium excretion and blood pressure within and across populations. BMJ. 1996;312:1249–53.
  • Forte JG, Miguel JM, Miguel MJ, de Padua F, Rose G. Salt and blood pressure: a community trial. J Hum Hypertens. 1989;3:179–84.
  • Tian HG, Guo ZY, Hu G, Yu SJ, Sun W, Pietinen P, . Changes in sodium intake and blood pressure in a community-based intervention project in China. J Hum Hypertens. 1995;9:959–68.
  • Takahashi Y, Sasaki S, Okubo S, Hayashi M, Tsugane S. Blood pressure change in a free-living population-based dietary modification study in Japan. J Hypertens. 2006; 24:451–8.
  • Staessen J, Bulpitt CJ, Fagard R, Joossens JV, Lijnen P, Amery A. Salt intake and blood pressure in the general population: a controlled intervention trial in two towns. J Hypertens. 1988;6:965–73.
  • Tuomilehto J, Puska P, Nissinen A, Salonen J, Tanskanen A, Pietinen P, . Community-based prevention of hypertension in North Karelia, Finland. Ann Clin Res. 1984;16 Suppl 43:18–27.
  • He FJ, MacGregor GA. Effect of modest salt reduction on blood pressure: a meta-analysis of randomized trials. Implications for public health. J Hum Hypertens. 2002; 16:761–70.
  • MacGregor GA, Markandu ND, Sagnella GA, Singer DR, Cappuccio FP. Double-blind study of three sodium intakes and long-term effects of sodium restriction in essential hypertension. Lancet. 1989;334:1244–7.
  • Sacks FM, Svetkey LP, Vollmer WM, Appel LJ, Bray GA, Harsha D, . Effects on blood pressure of reduced dietary sodium and the Dietary Approaches to Stop Hypertension (DASH) diet. DASH-Sodium Collaborative Research Group. N Engl J Med. 2001;344:3–10.
  • National Institute for Health and Clinical Excellence (NICE). Guidance on the prevention of cardiovascular disease at the population level. Available at: http://guidance.nice.org.uk/PH25 (accessed 14 July 2010).
  • Vollmer WM, Sacks FM, Ard J, Appel LJ, Bray GA, Simons-Morton DG, . Effects of diet and sodium intake on blood pressure: subgroup analysis of the DASH-sodium trial. Ann Intern Med. 2001;135:1019–28.
  • He FJ, Markandu ND, Sagnella GA, MacGregor GA. Importance of the renin system in determining blood pressure fall with salt restriction in black and white hypertensives. Hypertension. 1998;32:820–4.
  • He FJ, MacGregor GA. Salt, blood pressure and the renin-angiotensin system. J Renin Angiotensin Aldosterone Syst. 2003;4:11–16.
  • Whelton PK, He J, Appel LJ, Cutler JA, Havas S, Kotchen TA, . Primary prevention of hypertension: clinical and public health advisory from The National High Blood Pressure Education Program. JAMA. 2002;288:1882–8.
  • Lewington S, Clarke R, Qizilbash N, Peto R, Collins R; Prospective Studies Collaboration. Age-specific relevance of usual blood pressure to vascular mortality: a meta-analysis of individual data for one million adults in 61 prospective studies. Lancet. 2002;360:1903–13.
  • He FJ, MacGregor GA. How far should salt intake be reduced? Hypertension. 2003;42:1093–9.
  • Strazzullo P, D'Elia L, Kandala NB, Cappuccio FP. Salt intake, stroke, and cardiovascular disease: meta-analysis of prospective studies. BMJ. 2009;339:b4567.
  • Cook NR, Cutler JA, Obarzanek E, Buring JE, Rexrode KM, Kumanyika SK, . Long term effects of dietary sodium reduction on cardiovascular disease outcomes: observational follow-up of the trials of hypertension prevention (TOHP). BMJ. 2007;334:885–8.
  • Stolarz-Skrzypek K, Kuznetsova T, Thijs L, Tikhonoff V, Seidlerova J, Richart T, . Fatal and nonfatal outcomes, incidence of hypertension, and blood pressure changes in relation to urinary sodium excretion. JAMA. 2011;305: 1777–85.
  • He FJ, Appel LJ, Cappuccio FP, de Wardener HE, Macgregor GA. Does reducing salt intake increase cardiovascular mortality? Kidney Int. 2011;80:696–8.
  • Taylor RS, Ashton KE, Moxham T, Hooper L, Ebrahim S. Reduced dietary salt for the prevention of cardiovascular disease. Cochrane Database Syst Rev. 2011;(7):CD009217.
  • Taylor RS, Ashton KE, Moxham T, Hooper L, Ebrahim S. Reduced dietary salt for the prevention of cardiovascular disease: a meta-analysis of randomized controlled trials (Cochrane Review). Am J Hypertens. 2011;24:843–53.
  • Cutting down on salt doesn't reduce your chance of dying. Available at: http://eu.wiley.com/WileyCDA/PressRelease/pressReleaseId-99517.html (accessed 12 July 2011).
  • Paterna S, Gaspare P, Fasullo S, Sarullo FM, Di Pasquale P. Normal-sodium diet compared with low-sodium diet in compensated congestive heart failure: is sodium an old enemy or a new friend? Clin Sci (Lond). 2008;114: 221–30.
  • He FJ, MacGregor GA. Salt reduction lowers cardiovascular risk: meta-analysis of outcome trials. Lancet. 2011;378: 380–2.
  • Dahl LK, Heine M, Thompson K. Genetic influence of renal homografts on the blood pressure of rats from different strains. Proc Soc Exp Biol Med. 1972;140:852–6.
  • Dahl LK, Heine M, Thompson K. Genetic influence of the kidneys on blood pressure. Evidence from chronic renal homografts in rats with opposite predispositions to hypertension. Circ Res. 1974;40:94–101.
  • Guyton AC. Blood pressure control—special role of the kidneys and body fluids. Science. 1991;252:1813–6.
  • He FJ, Markandu ND, Sagnella GA, de Wardener HE, MacGregor GA. Plasma sodium: ignored and underestimated. Hypertension. 2005;45:98–102.
  • Suckling RJ, He FJ, Markandu ND, MacGregor GA. Dietary salt influences post prandial plasma sodium concentration and systolic blood pressure. Kidney Int. 2012;81:407–11.
  • Bulpitt CJ, Shipley MJ, Semmence A. Blood pressure and plasma sodium and potassium. Clin Sci (Lond). 1981;61 Suppl 7:85s–7s.
  • Komiya I, Yamada T, Takasu N, Asawa T, Akamine H, Yagi N, . An abnormal sodium metabolism in Japanese patients with essential hypertension, judged by serum sodium distribution, renal function and the renin-aldosterone system. J Hypertens. 1997;15:65–72.
  • Wannamethee G, Whincup PH, Shaper AG, Lever AF. Serum sodium concentration and risk of stroke in middle-aged males. J Hypertens. 1994;12:971–9.
  • Lago RM, Pencina MJ, Wang TJ, Lanier KJ, D'Agostino RB, Kannel WB, . Interindividual variation in serum sodium and longitudinal blood pressure tracking in the Framingham Heart Study. J Hypertens. 2008;26:2121–5.
  • de Wardener HE, He FJ, MacGregor GA. Plasma sodium and hypertension. Kidney Int. 2004;66:2454–66.
  • Friedman SM, McIndoe RA, Tanaka M. The relation of blood sodium concentration to blood pressure in the rat. J Hypertens. 1990;8:61–6.
  • Friedman SM. The relation of cell volume, cell sodium and the transmembrane sodium gradient to blood pressure. J Hypertens. 1990;8:67–73.
  • Suckling RJ, Swift P, Markandu N, He F, MacGregor GA. Altering plasma sodium concentration rapidly changes blood pressure during haemodialysis. J Hum Hypertens. 2010; 24:S10.
  • Gu J, Anand V, Shek E, Moore M, Brady A, Kelly W, . Sodium induces hypertrophy of cultured myocardial myoblasts and vascular smooth muscle cells. Hypertension. 1998; 31:1083–7.
  • Li J, White J, Guo L, Zhao X, Wang J, Smart EJ, . Salt inactivates endothelial nitric oxide synthase in endothelial cells. J Nutr. 2009;139:447–51.
  • Oberleithner H, Riethmuller C, Schillers H, MacGregor GA, de Wardener HE, Hausberg M. Plasma sodium stiffens vascular endothelium and reduces nitric oxide release. Proc Natl Acad Sci U S A. 2007;104:16281–6.
  • Dickinson KM, Keogh JB, Clifton PM. Effects of a low-salt diet on flow-mediated dilatation in humans. Am J Clin Nutr. 2009;89:485–90.
  • Tzemos N, Lim PO, Wong S, Struthers AD, MacDonald TM. Adverse cardiovascular effects of acute salt loading in young normotensive individuals. Hypertension. 2008;51: 1525–30.
  • Dickinson KM, Clifton PM, Keogh JB. Endothelial function is impaired after a high-salt meal in healthy subjects. Am J Clin Nutr. 2011;93:500–5.
  • Selmer RM, Kristiansen IS, Haglerod A, Graff-Iversen S, Larsen HK, Meyer HE, . Cost and health consequences of reducing the population intake of salt. J Epidemiol Community Health. 2000;54:697–702.
  • Joffres MR, Campbell NR, Manns B, Tu K. Estimate of the benefits of a population-based reduction in dietary sodium additives on hypertension and its related health care costs in Canada. Can J Cardiol. 2007;23:437–43.
  • Asaria P, Chisholm D, Mathers C, Ezzati M, Beaglehole R. Chronic disease prevention: health effects and financial costs of strategies to reduce salt intake and control tobacco use. Lancet. 2007;370:2044–53.
  • Murray CJ, Lauer JA, Hutubessy RC, Niessen L, Tomijima N, Rodgers A, . Effectiveness and costs of interventions to lower systolic blood pressure and cholesterol: a global and regional analysis on reduction of cardiovascular-disease risk. Lancet. 2003;361:717–25.
  • Bibbins-Domingo K, Chertow GM, Coxson PG, Moran A, Lightwood JM, Pletcher MJ, . Projected effect of dietary salt reductions on future cardiovascular disease. N Engl J Med. 2010;362:590–9.
  • Palar K, Sturm R. Potential societal savings from reduced sodium consumption in the U.S. adult population. Am J Health Promot. 2009;24:49–57.
  • Smith-Spangler CM, Juusola JL, Enns EA, Owens DK, Garber AM. Population strategies to decrease sodium intake and the burden of cardiovascular disease: a cost-effectiveness analysis. Ann Intern Med. 2010;152:481–7, W170–3.
  • Food Standards Agency. Dietary sodium levels surveys, 22 July 2008. Available at: http://www.food.gov.uk/science/dietary surveys/urinary (accessed 28 May 2010).
  • Ofcom, Office of Communications. Impact assessment. Available at: http://stakeholders.ofcom.org.uk/binaries/consultations/foodads_new/ia.pdf (accessed 13 July 2010).
  • James WP, Ralph A, Sanchez-Castillo CP. The dominance of salt in manufactured food in the sodium intake of affluent societies. Lancet. 1987;1:426–9.
  • Karppanen H, Mervaala E. Sodium intake and hypertension. Prog Cardiovasc Dis. 2006;49:59–75.
  • Pietinen P, Valsta LM, Hirvonen T, Sinkko H. Labelling the salt content in foods: a useful tool in reducing sodium intake in Finland. Public Health Nutr. 2008;11:335–40.
  • Laatikainen T, Pietinen P, Valsta L, Sundvall J, Reinivuo H, Tuomilehto J. Sodium in the Finnish diet: 20-year trends in urinary sodium excretion among the adult population. Eur J Clin Nutr. 2006;60:965–70.
  • Consensus Action on Salt and Health. Available at: http://www.actiononsalt.org.uk/ (accessed 28 May 2010).
  • MacGregor GA, Sever PS. Salt—overwhelming evidence but still no action: can a consensus be reached with the food industry? CASH (Consensus Action on Salt and Hypertension). BMJ. 1996;312:1287–9.
  • Henderson L, Irving K, Gregory J, Bates CJ, Prentice A, Perks J, . Urinary analytes. In: National Diet & Nutrition Survey: Adults aged 19 to 64. Volume 3. London: TSO; 2003. p. 127–36.
  • Girgis S, Neal B, Prescott J, Prendergast J, Dumbrell S, Turner C, . A one-quarter reduction in the salt content of bread can be made without detection. Eur J Clin Nutr. 2003;57:616–20.
  • Food Standards Agency. Agency publishes 2012 salt reduction targets, 8 May 2009. Available at: http://www.food.gov.uk/news/newsarchive/2009/may/salttargets (accessed 28 May 2010).
  • World Action on Salt and Health. Press release—Medical experts launch global campaign against salt to prevent over 2.5 million deaths worldwide each year. Available at: http://www.worldactiononsalt.com/media/Media_coverage/Archive_Wash_Launch.htm (accessed 28 May 2010).
  • AWASH, Australian Division of World Action on Salt and Health. Available at: http://www.awash.org.au/ (accessed 28 May 2010).
  • He FJ, Jenner KH, MacGregor GA. WASH—World Action on Salt and Health. Kidney Int. 2010;78:745–53.
  • Webster JL, Dunford EK, Hawkes C, Neal BC. Salt reduction initiatives around the world. J Hypertens. 2011;29:1043–50.
  • Reducing salt intake in populations. WHO Forum and Technical Meeting on Reducing Salt Intake in Populations. Available at: http://www.who.int/dietphysicalactivity/reducingsalt/en/index.html (accessed 28 May 2010).
  • Pan American Health Organization (PAHO)/WHO. Cardiovascular disease prevention through dietary salt reduction. Available at: http://new.paho.org/hq/index.php?option = com_content&task = view&id = 2015&Itemid = 1757 (accessed 28 May 2010).
  • Campbell NR, Neal BC, MacGregor GA. Interested in developing a national programme to reduce dietary salt? J Hum Hypertens. 2011;25:705–10.
  • Food Standards Agency. Traffic light labelling, Signposting. Available at: http://www.food.gov.uk/foodlabelling/signposting/ (accessed 28 May 2010).
  • Law MR, Frost CD, Wald NJ. By how much does dietary salt reduction lower blood pressure? I—Analysis of observational data among populations. BMJ. 1991;302: 811–5.
  • First global ministerial conference on healthy lifestyles and noncommunicable disease control, 28–29 April 2011, Moscow. Available at: http://www.who.int/nmh/events/moscow_ncds_2011/en/ (accessed 16 May 2011).
  • Beaglehole R, Bonita R, Horton R, Adams C, Alleyne G, Asaria P, . Priority actions for the non-communicable disease crisis. Lancet. 2011;377:1438–47.
  • Lawes CM, Vander Hoorn S, Rodgers A. Global burden of blood-pressure-related disease, 2001. Lancet. 2008;371: 1513–8.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.